0001209191-22-058923.txt : 20221128 0001209191-22-058923.hdr.sgml : 20221128 20221128213545 ACCESSION NUMBER: 0001209191-22-058923 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221123 FILED AS OF DATE: 20221128 DATE AS OF CHANGE: 20221128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JANKOWSKI JESS CENTRAL INDEX KEY: 0001184478 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22333 FILM NUMBER: 221428157 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NANOPHASE TECHNOLOGIES Corp CENTRAL INDEX KEY: 0000883107 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS PRIMARY METAL PRODUCTS [3390] IRS NUMBER: 363687863 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1319 MARQUETTE DRIVE CITY: ROMEOVILLE STATE: IL ZIP: 60446 BUSINESS PHONE: 6303231200 MAIL ADDRESS: STREET 1: 1319 MARQUETTE DRIVE CITY: ROMEOVILLE STATE: IL ZIP: 60446 FORMER COMPANY: FORMER CONFORMED NAME: NANOPHASE TECHNOLOGIES CORPORATION DATE OF NAME CHANGE: 19970305 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-11-23 0 0000883107 NANOPHASE TECHNOLOGIES Corp NANX 0001184478 JANKOWSKI JESS 1319 MARQUETTE DRIVE ROMEOVILLE IL 60446 1 1 0 0 President, CEO Common Stock 1000 I Spouse's IRA Common Stock 59000 D Common Stock 2022-11-23 4 M 0 1500 0.415 A 60500 D Common Stock 2022-11-23 4 S 0 1500 1.40 D 59000 D Common Stock 2022-11-25 4 M 0 3000 0.415 A 62000 D Common Stock 2022-11-25 4 S 0 3000 1.39 D 59000 D Common Stock (right to purchase) 0.415 2022-11-23 4 M 0 1500 0.415 D 2014-02-14 2023-02-14 Common Stock 31626 30126 D Common Stock (right to purchase) 0.415 2022-11-25 4 M 0 3000 0.415 D 2014-02-14 2023-02-14 Common Stock 30126 27126 D Common Stock (right to purchase) 0.52 2015-02-13 2024-02-13 Common Stock 90000 90000 D Common Stock (right to purchase) 0.44 2016-02-18 2025-02-18 Common Stock 81000 81000 D Common Stock (right to purchase) 0.42 2017-02-23 2026-02-23 Common Stock 69000 69000 D Common Stock (right to purchase) 0.68 2018-02-21 2027-02-21 Common Stock 81000 81000 D Common Stock (right to purchase) 0.82 2019-05-23 2028-05-23 Common Stock 90000 90000 D Common Stock (right to purchase) 0.51 2020-05-22 2029-05-22 Common Stock 16500 16500 D Common Stock (right to purchase) 0.45 2021-06-18 2027-06-18 Common Stock 90000 90000 D Common Stock (right to purchase) 4.17 2022-12-28 2028-12-28 Common Stock 90000 90000 D These stock options are set to expire on 02/14/2023. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors. If not sold through a 10b5-1 Plan, Nanophase trading blackout periods run from the 25th of the last day of any given quarter until 3 days after earnings are released. In example, for options expiring during the 1st quarter of any given year, trading would be prohibited from December 25th of the prior year, through the release of annual earnings plus 3 business days. Typically, this would reopen trading in early-to-mid March, through March 24th. The next blackout period would begin on March 25th, etc. The price reported is a weighted average price. These shares were sold through multiple transactions, five in all, at prices ranging from $1.40 to $1.40. The price reported is a weighted average price. These shares were sold through multiple transactions, four in all, at prices ranging from $1.35 to $1.41. These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker. His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors. Subject to certain restrictions, beginning on this date, options vest in three equal installments. Subject to certain restrictions, beginning on this date, the options vest in three equal annual installments. Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having shares from this grant sold, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors. The maturity of these rights cannot be extended beyond the IRS statutory limit of ten years. Jess A. Jankowski 2022-11-28